FDA 483 - AR Fabricating - February 11, 2026

An FDA inspection of AR Fabricating in Georgetown, TX, a manufacturer of Class II medical devices, revealed significant deficiencies in their quality system. The firm failed to adequately validate critical manufacturing processes, lacked documented procedures for key production controls, and did not properly evaluate or monitor its suppliers. These issues indicate a systemic breakdown in ensuring product quality and safety.